Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China.

Lu XieWei GuoYe WangTaiqiang YanTao JiJie Xu

Published in: BMC cancer (2018)

Retrospectively registered in the Medical Ethics Committee of Peking University People's Hospital, Peking University Shougang Hospital and Peking University International Hospital. The trial registration number is 2017PHB176-03 and the date of registration is January 20th 2017.

Keyphrases

healthcare
adverse drug
clinical trial
public health
randomized controlled trial
study protocol
phase ii
big data
phase iii
drug induced
electronic health record
open label
global health